Dear colleagues, patients, families, and caregivers,
We are pleased to announce the 4th Global Congress on Sickle Cell Disease will convene in Paris on June 16-18, 2022.
Sickle cell disease is one the world’s most prevalent genetic diseases. Major advances have been made in understanding the disease, paving the way for new and effective treatments. Neonatal screening is developing in many countries, resulting in early prevention of
infections and improved parental education. New preventive…
About the congress
The Congress will bring together sickle cell diseases (SCD) stakeholders from various sectors, including clinicians, scientists, patients, health policy makers and advocacy groups to catalyze discussion around the achievements and challenges in the diagnosis, treatment and care of people living with SCD globally, as well as the prospects for further progress.